Preventive anti-edema action of Casperiva® (Retimix®) in cataract surgery

BACKGROUND: The prevention of postoperative cystoid macular edema (PCME) continues to be a challenge for many ophthalmologists. The occurrence of a cystoid macular edema can, in fact, delay and reduce the result of cataract surgery that has otherwise been performed correctly, causing a reduction in and a poor quality of final vision.METHODS: A prospective observational cohort study to assess the effective incidence of PCME in diabetic and non-diabetic patients treated with Retimix® after uncomplicated cataract surgery. The comparison was made between the two eyes of the same patient, one treated with Retimix® and the other not (cross-over).RESULTS: Only 6% of the eyes of diabetic patients who were given Retimix® exhibited postoperative cystoid macular edema, compared with 12% of those who did not take the treatment. In postoperative controls, the vision of patients with PCME was 3/10 and 4/10 lower than in the other patients.CONCLUSIONS: The finding on diabetic patients is particularly interesting, as it could suggest a possible protective effect of Retimix® on the occurrence of postoperative cystoid macular edema.